Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study
暂无分享,去创建一个
M. Pinter | F. Frommlet | C. Lechner | H. Haslacher | M. Maestri | W. Pirker | S. Pirker | M. Valach | S. Hametner | T. Perkmann | N. Kozakowski | M. Guida | A. De Rosa | V. Endmayr | D. De Simoni | R. Ricciardi | I. Koneczny | C. Tunc | A. Angelovski | D. Sieghart | G. Ricken | C. Schwaiger | R. Weng | A. Fichtenbaum | L. Wagner | T.-Y. Yu | L. Ergin | L. Almeida Dutra | K. Poppert | G. J. Mampuumlller | R. Hampoumlftberger | V. Endmayr
[1] D. Tang,et al. Mechanisms of Primary Membranous Nephropathy , 2021, Biomolecules.
[2] A. Fernández-Codina,et al. Emerging therapy options for IgG4-related disease , 2021, Expert review of clinical immunology.
[3] F. Leypoldt,et al. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common? , 2021, Frontiers in Immunology.
[4] H. Cathro,et al. Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy , 2020, Kidney medicine.
[5] J. Stone,et al. IgG4-related disease: an update on pathophysiology and implications for clinical care , 2020, Nature Reviews Rheumatology.
[6] A. Vincent,et al. Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment , 2020, Frontiers in Molecular Neuroscience.
[7] I. Koneczny. Update on IgG4-mediated autoimmune diseases: New insights and new family members. , 2020, Autoimmunity reviews.
[8] B. Qaqish,et al. A Lutzomyia longipalpis salivary protein induces cross-reactive antibodies to pemphigus autoantigen desmoglein-1. , 2020, The Journal of investigative dermatology.
[9] J. Stone,et al. Immunoglobulin G (IgG) and IgG Subclass Concentrations Differ According to Sex and Race. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[10] C. Terao,et al. Genetic analysis of IgG4-related disease , 2020, Modern rheumatology.
[11] Amita Sharma,et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease , 2019, Annals of the rheumatic diseases.
[12] Y. Parman,et al. Relation of HLA‐DRB1 to IgG4 autoantibody and cytokine production in muscle‐specific tyrosine kinase myasthenia gravis (MuSK‐MG) , 2019, Clinical and experimental immunology.
[13] N. Gilhus,et al. Myasthenia gravis , 2019, Nature Reviews Disease Primers.
[14] G. Kasprian,et al. Two Cases of Pediatric AQP4-Antibody Positive Neuromyelitis Optica Spectrum Disorder Successfully Treated with Tocilizumab , 2019, Neuropediatrics.
[15] M. Kawakami,et al. Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature , 2019, Immunologic Research.
[16] M. Kawano,et al. The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease? , 2019, Modern rheumatology.
[17] D. Salant. Unmet challenges in membranous nephropathy , 2019, Current opinion in nephrology and hypertension.
[18] Yong-Beom Park,et al. No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study , 2018, Clinical Rheumatology.
[19] J. Hainfellner,et al. Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank , 2018, Biopreservation and biobanking.
[20] J. Kira,et al. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey , 2018, Front. Neurol..
[21] U. Rescher,et al. Annexins in Translational Research: Hidden Treasures to Be Found , 2018, International journal of molecular sciences.
[22] K. Nakanishi,et al. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis , 2018, BMC Nephrology.
[23] A. Erickson,et al. IgG-4 Related Disease: An Introduction. , 2018, Missouri medicine.
[24] I. Koneczny. A New Classification System for IgG4 Autoantibodies , 2018, Front. Immunol..
[25] P. Guilpain,et al. Comment on the article entitled "Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome" (Autoimmunity Reviews 16 (2017) 1036-1043). , 2018, Autoimmunity reviews.
[26] H. Vos,et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease , 2017, Gut.
[27] J. Stone,et al. Medical mirroring: granulomatosis with polyangiitis (formerly Wegener's) mimicking immunoglobulin‐G4 related disease , 2015, International journal of rheumatic diseases.
[28] A. Vaglio,et al. Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome. , 2017, Autoimmunity reviews.
[29] M. Titulaer,et al. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies) , 2017, Current opinion in neurology.
[30] Andreas Handel,et al. Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells , 2017, Nature.
[31] J. Stone,et al. Is MuSK myasthenia gravis linked to IgG4-related disease? , 2017, Journal of Neuroimmunology.
[32] Y. Shoenfeld,et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity , 2017, Immunologic research.
[33] L. Marshall,et al. Pemphigus , 2017, Nature Reviews Disease Primers.
[34] E. Sánchez,et al. Anti-LGI1 encephalitis , 2016, Neurology.
[35] J. Stone,et al. Antineutrophil cytoplasmic antibody positivity in IgG4-related disease , 2016, Medicine.
[36] Tomohiro Watanabe,et al. Pathogenicity of IgG in patients with IgG4-related disease , 2016, Gut.
[37] J. Verschuuren,et al. The expanding field of IgG4‐mediated neurological autoimmune disorders , 2015, European journal of neurology.
[38] A. Payne,et al. The dual nature of interleukin-10 in pemphigus vulgaris. , 2015, Cytokine.
[39] E. Rosser,et al. Regulatory B cells: origin, phenotype, and function. , 2015, Immunity.
[40] Kenichi Yoshida,et al. A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis , 2015, Pituitary.
[41] E. Lerma,et al. Thrombotic thrombocytopenic purpura. , 2014, Disease-a-month : DM.
[42] P. Christadoss,et al. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice. , 2014, Clinical immunology.
[43] R. Blesa,et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg , 2014, Neurology.
[44] P. Young. [Granulomatosis with polyangiitis]. , 2014, Medicina.
[45] C. Palazzo,et al. IgG4-related disease. , 2014, Joint, bone, spine : revue du rhumatisme.
[46] A. Vincent,et al. MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters , 2013, PloS one.
[47] C. Akdis,et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. , 2013, The Journal of allergy and clinical immunology.
[48] R. Takayanagi,et al. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. , 2013, World journal of gastroenterology.
[49] M. Uhlén,et al. Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation. , 2013, Kidney international.
[50] T. Funakoshi,et al. Enrichment of total serum IgG4 in patients with pemphigus , 2012, The British journal of dermatology.
[51] D. Sahani,et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. , 2012, Arthritis and rheumatism.
[52] A. Masamune,et al. Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009 , 2012, International journal of rheumatology.
[53] J. Ryu,et al. Increased IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis: A Diagnostic Pitfall of IgG4-Related Disease , 2012, International journal of rheumatology.
[54] Hisanori UmeharaKazuichi. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details , 2012 .
[55] I. Narita,et al. Thrombotic thrombocytopenic purpura in IgG4‐related disease with severe deficiency of ADAMTS‐13 activity and IgG4 autoantibody against ADAMTS‐13 , 2011, Arthritis care & research.
[56] K. Strauss,et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia , 2011, Annals of neurology.
[57] C. Akdis,et al. In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure , 2008, The Journal of experimental medicine.
[58] C. Akdis,et al. Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll‐like receptors , 2008, Allergy.
[59] T. Nishikawa,et al. Novel System Evaluating In Vivo Pathogenicity of Desmoglein 3-Reactive T Cell Clones Using Murine Pemphigus Vulgaris1 , 2008, The Journal of Immunology.
[60] P. Parren,et al. Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange , 2007, Science.
[61] C. Hung,et al. Glomerulonephritis Associated with Chronic Inflammatory Demyelinating Polyneuropathy , 2006, Renal failure.
[62] A. Hoerauf,et al. T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-101 , 2005, The Journal of Immunology.
[63] H. Emsley,et al. Inflammatory demyelinating polyradiculoneuropathy associated with membranous glomerulonephritis and thrombocytopaenia , 2002, Clinical Neurology and Neurosurgery.
[64] David Gray,et al. B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.
[65] R. Blumberg,et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. , 2002, Immunity.
[66] T. Nishikawa,et al. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. , 2002, The Journal of investigative dermatology.
[67] J. Russell,et al. Chronic inflammatory demyelinating polyneuropathy and membranous glomerulonephropathy: report of two cases. , 2001, Journal of clinical neuromuscular disease.
[68] R. Mobbs,et al. Chronic inflammatory demyelinating polyneuropathy associated with membranous glomerulonephritis: case report , 2000, Journal of Clinical Neuroscience.
[69] M. Nagata,et al. [Renal glucosuria and membranous glomerulonephritis in chronic inflammatory demyelinating polyradiculoneuropathy: CIDP]. , 1999, Nihon Jinzo Gakkai shi.
[70] J. Bonnefoy,et al. IgE versus IgG4 production can be differentially regulated by IL-10. , 1998, Journal of immunology.
[71] G. Eknoyan,et al. Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[72] P. Vialtel,et al. Beneficial effect of one HLA haplo- or semi-identical transfusion versus three untyped blood units on alloimmunization and acute rejection episodes in first renal allograft recipients. , 1995, Transplantation.
[73] D. Bronson,et al. Identification and characterization of the human cell adhesion molecule contactin. , 1994, Brain research. Molecular brain research.
[74] R. de Waal Malefyt,et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[75] V. Kher,et al. Chronic inflammatory demyelinating polyradiculoneuropathy with membranous glomerulonephritis: report of one case , 1992, Clinical Neurology and Neurosurgery.
[76] F. Boctor,et al. IgG subclasses in human chronic schistosomiasis: over‐production of schistosome‐specific and non‐specific IgG4 , 1990, Clinical and experimental immunology.
[77] J. Burke,et al. Membranous glomerulonephritis associated with chronic progressive demyelinating neuropathy , 1987, Neurology.
[78] M. Daveau,et al. Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies. , 1984, Journal of immunological methods.
[79] D. Kemeny,et al. Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens. , 1983, The Journal of allergy and clinical immunology.
[80] D. Kemeny,et al. Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy. , 1983, Monographs in allergy.